Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its ...
A small pharma company in RTP is expanding its portfolio and staff following a new licensing agreement with a California firm. A small pharma company in Research Triangle Park is expanding its ...
RESEARCH TRIANGLE PARK, N.C, Oct. 22, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating ...
RESEARCH TRIANGLE PARK – Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a ...
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological ...
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr.
RESEARCH TRIANGLE PARK, N.C., Oct. 1, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a specialty pharma company focused on resorting bowel and bladder function in patients with neurological ...
White House homeland security adviser Tom Bossert on Sunday defended President Trump’s decision to not specifically name hate groups in his condemnation of the violence at a white supremacist rally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results